A revenue-generating, small-cap Canadian pharmaceutical company

Revenue Projected at $150,000,000 by 2025

Free
Discussion Forum: Valeo Pharma Inc.
List Message View
Thread Message View
New Message
Message Title
Rating
Author / Date
Icon agoracom VALEO PHARMA ENTERS INTO AN AGREEMENT FOR OPHTHALMIC PRODUCTS, PrXIIDRA® AND PrSIMBRINZA®, IN CANADA

AGORACOM-KE
Aug 02, 2022 07:00AM
Re: Valeo Pharma Secures Additional Public Reimbursement For Redesca™, Enerzair® Breezhaler® And Atectura® Breezhaler®

run3donlineaz
Jul 30, 2022 04:34AM
Re: Valeo Pharma Inc. Opens the Market

run3donlineaz
Jul 30, 2022 04:33AM
Re: Valeo Pharma Inc. Opens the Market

peppor35352
Jul 08, 2022 05:42AM
Re: VALEO PHARMA REPORTS ITS SECOND QUARTER 2022 RESULTS AND HIGHLIGHTS

penny35598
Jul 08, 2022 05:15AM
Re: Valeo Pharma To Host First Quarter 2022 Results Conference Call / Webcast And Attend The 8Th Annual Alphanorth Capital Conference

penny5575
Jul 08, 2022 04:17AM
Icon agoracom VALEO PHARMA REPORTS ITS SECOND QUARTER 2022 RESULTS AND HIGHLIGHTS

AGORACOM-KE
Jun 14, 2022 05:55PM
Icon agoracom VALEO PHARMA TO HOST SECOND QUARTER 2022 RESULTS CONFERENCE CALL / WEBCAST

AGORACOM-KE
Jun 08, 2022 07:00AM
Icon agoracom Valeo Pharma Inc. Opens the Market

AGORACOM-KE
May 09, 2022 11:00AM
Re: AGORACOM Small Cap 60: 2022 Is Shaping Up To Be Transformational Year For Valeo Pharma (VPH: CSE)

malinkastrong
May 05, 2022 10:01AM
Icon agoracom VALEO PHARMA ANNOUNCES RESULTS OF ANNUAL MEETING OF SHAREHOLDERS, APPOINTMENTS AND OPTIONS AND RSU GRANTS

AGORACOM-KE
Apr 28, 2022 08:51AM
Icon agoracom VALEO PHARMA TO PRESENT AT THE 2022 BLOOM BURTON & CO HEALTHCARE INVESTOR CONFERENCE

AGORACOM-KE
Apr 25, 2022 07:00AM
Icon agoracom Valeo Pharma Announces Listing Of Convertible Debentures On TSX

AGORACOM-KE
Apr 19, 2022 07:00AM
Icon agoracom AGORACOM Small Cap 60: 2022 Is Shaping Up To Be Transformational Year For Valeo Pharma (VPH: CSE)

AGORACOM-KE
Apr 18, 2022 05:53PM
Icon agoracom Valeo Pharma Announces Listing To The Toronto Stock Exchange

AGORACOM-KE
Mar 28, 2022 07:00AM
Icon agoracom VALEO PHARMA REPORTS ITS FIRST QUARTER 2022 RESULTS AND HIGHLIGHTS

AGORACOM
Mar 24, 2022 05:41PM
Icon agoracom Valeo Pharma Reports Its First Quarter 2022 Results And Highlights

AGORACOM-KE
Mar 24, 2022 05:41PM
Icon agoracom AGORACOM Small Cap 60: Valeo Pharma (VPH: CSE) (VPHIF: OTCQB) Asthma Drug Could Become Top Selling Product In Canada

AGORACOM-KE
Mar 22, 2022 02:43PM
Icon agoracom Valeo Pharma Secures Additional Public Reimbursement For Redesca™, Enerzair® Breezhaler® And Atectura® Breezhaler®

AGORACOM-KE
Mar 22, 2022 07:00AM
Icon agoracom AGORACOM Small Cap 60: Valeo Pharma (VPH: CSE) (VPHIF: OTCQB) Experiencing Month Over Month Prescription Growth For Asthma Drugs

AGORACOM-KE
Mar 21, 2022 11:20AM
New Message